High-Performance Liquid Chromatography (HPLC) Market is expected to foresee significant growth. North America leads the Market!
- Vikas Kumar
- December 24, 2021
- HEALTHCARE, NEWS
- High-Performance Liquid Chromatography (HPLC) Market Growth, High-Performance Liquid Chromatography (HPLC) Market news, High-Performance Liquid Chromatography (HPLC) Market Share, High-Performance Liquid Chromatography (HPLC) Market Size, High-Performance Liquid Chromatography (HPLC) Market Trend
- 0 Comments
High-Performance Liquid Chromatography (HPLC) Market is expected to grow at a CAGR of around 5% over the forecast period (2021-2027). The high sensitivity and precision of the HPLC technology, the expanding importance of HPLC tests in drug approvals, the growing use of hyphenated procedures, and rising pharmaceutical R&D spending are all driving this industry forward. The high cost of HPLC systems, on the other hand, is projected to limit market expansion to some extent.
Furthermore, the HPLC market is likely to benefit from an increase in pharmaceutical, biotech, food, and agriculture research and development. Patented research and an increase in clinical trial enrollment will undoubtedly improve the market. During the projected period, the consumables market is expected to grow at the fastest rate. For clinical trials or research, an HPLC apparatus is essential. Inorganic impurities, such as plant or animal proteins, must be identified in pharmaceutical bulk materials, excipients, or catalysts. It can also be used to test organic substances. Clinical research is the process of evaluating a newly developed medicine.
For a detailed analysis of the market drivers browse through https://univdatos.com/report/high-performance-liquid-chromatography-hplc-market/
COVID-19 quickly spread and became an epidemic, affecting nearly every country and area on the planet. According to World Health Organization reports, the COVID-19 case death rate ranges from 1% to 7%. As the COVID-19 epidemic spreads and has the potential to affect global health, active treatment alternatives are desperately needed. Several drugs, including chloroquine, arbidol, remdesivir, and favipiravir, are currently being tested in clinical studies in several countries to determine their efficacy and safety in treating coronavirus disease. There is currently no gold standard for the treatment of COVID-19 due to a lack of evidence. However, in June 2020, liquid chromatography with mass spectrometry was used to measure remdesivir in the blood plasma of a COVID-19 patient, providing data on its efficacy as a SARS-CoV-2 treatment. It was one of the first treatments in the United States to be approved by the Food and Drug Administration.
For a detailed analysis of the Covid-19 Impact on the market browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=12850
Based on Product, the market is segmented into Instruments, Consumables, and Accessories. The Instruments segment leads the High-Performance Liquid Chromatography (HPLC) Market. Further, the instruments is bifurcated into systems and detectors and Consumables is fragmented into columns and filters. Based on Application, the High-Performance Liquid Chromatography (HPLC) market is segmented into Clinical Research, Diagnostics, and Forensics. The Clinical Research segment contributed the maximum market to the High-Performance Liquid Chromatography (HPLC) market.
For a better understanding of the market adoption of High-Performance Liquid Chromatography (HPLC) systems, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. North America dominated the market in 2020.
Some of the major players operating in the market include Thermo Fisher, PerkinElmer, GE Healthcare, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Hitachi, Merck Millipore, Shimadzu Corporation, Showa Denko, Waters Corporation, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions
Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=12850
High-Performance Liquid Chromatography (HPLC) Market Segmentation
Market Insight, by Product
- Instruments
- Systems
- Detectors
- Consumables
- Columns
- Filters
- Accessories
Market Insight, by Application
- Clinical Research
- Diagnostics
- Forensics
Market Insight, by Region
- North America High-Performance Liquid Chromatography (HPLC) Market
- United States
- Canada
- Rest of North America
- Europe High-Performance Liquid Chromatography (HPLC) Market
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia Pacific High-Performance Liquid Chromatography (HPLC) Market
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Rest of High-Performance Liquid Chromatography (HPLC) Market
Company Profiled
- Thermo Fisher
- PerkinElmer
- GE Healthcare
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Hitachi
- Merck Millipore
- Waters Corporation
- Shimadzu Corporation
- Showa Denko
